1-2 of 2
Zhao Hai Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy

David A. Schaer, Sandaruwan Geeganage, Nelusha Amaladas, Zhao Hai Lu, Erik R. Rasmussen, Andreas Sonyi, Darin Chin, Andrew Capen, Yanxia Li, Catalina M. Meyer, Bonita D. Jones, Xiaodong Huang, Shuang Luo, Carmine Carpenito, Kenneth D. Roth, Alexander Nikolayev, Bo Tan, Manisha Brahmachary, Krishna Chodavarapu, Frank C. Dorsey, Jason R. Manro, Thompson N. Doman, Gregory P. Donoho, David Surguladze, Gerald E. Hall, Michael Kalos, Ruslan D. Novosiadly
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 7175–7188.
https://doi.org/10.1158/1078-0432.CCR-19-0433
Published: 02 December 2019
View article titled, The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
Open the PDF for The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

AKT-1, -2, and -3 are Expressed in Both Normal and Tumor Tissues of the Lung, Breast, Prostate, and Colon

Michael J. Zinda, Mac A. Johnson, Jonathan D. Paul, Candice Horn, Bruce W. Konicek, Zhao Hai Lu, George Sandusky, James E. Thomas, Blake Lee Neubauer, Mei T. Lai, Jeremy R. Graff
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2475–2479.
Published: 01 August 2001
View article titled, AKT-1, -2, and -3 are Expressed in Both Normal and Tumor Tissues of the Lung, Breast, Prostate, and Colon
Open the PDF for AKT-1, -2, and -3 are Expressed in Both Normal and Tumor Tissues of the Lung, Breast, Prostate, and Colon in another window